サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：DNA修復薬の世界市場：薬剤タイプ別、用途別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測
市場調査レポート
商品コード
1339881

DNA修復薬の世界市場：薬剤タイプ別、用途別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測

DNA Repair Drugs Market with COVID-19 Impact Analysis, By Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 300 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
DNA修復薬の世界市場：薬剤タイプ別、用途別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 300 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のDNA修復薬の市場規模は、2022年は60億520万米ドルとなり、2023年から2030年にかけてCAGR 12.8%で拡大すると予想されています。

DNA修復薬市場 - 市場力学

  • がん患者の増加と医療インフラの整備が市場需要を促進。
  • 世界中でがんの症例が増加していることから、がんのアンメットニーズを解決するためにDNA損傷応答薬を開発する必要性が著しく高まっています。これらの薬剤は、がんの生存率を高めるための特異的かつ効果的に耐容性のある治療法を提供するという、これまでにない可能性を秘めています。さらに、DNA修復薬は、患者の遺伝的体質や特定の変異に基づいて医療を個別化する個別化医療の考え方としばしば関連しています。したがって、薬剤は選択的な遺伝子プロファイルに合わせて設計することができます。その結果、この動向はこれらの薬剤の潜在的な市場を押し上げるのに役立ちます。しかし、市場関係者にとっては、DNA修復薬の規制当局の承認取得は時間がかかり、複雑なプロセスであるため、世界の市場成長を抑制する可能性があります。さらに、新興国における医療費の増加とヘルスケア・インフラの成長は、DNA修復薬メーカーに大きな成長機会を提供します。さらに、これらの地域では効果的な治療法に対するアンメットニーズがあり、膨大な患者人口が良好な市場環境を作り出しているため、DNA修復市場の成長を後押しすると予測されます。

DNA修復薬市場 - セグメンテーション分析

  • 世界のDNA修復薬市場は、薬剤タイプ、用途、流通チャネル、地域によって区分されます。
  • 薬剤タイプにより、アルキル化剤、PARP阻害剤、トポイソメラーゼ阻害剤、その他に分類されます。市場セグメンテーションでは、PARP阻害剤が最も大きなシェアを占めています。相同組換え修復（HRR）経路や転移性前立腺がん、トリプルネガティブ乳がんなどを標的とするPARP阻害剤の使用は、市場規模を拡大させると予想されます。さらに、オラパリブ、ニラパリブ、ルカパリブなどのPARP阻害剤が、BRCA1/2遺伝子変異やHRR欠損を有するがん患者に利用されることで、同分野の市場規模が拡大すると予測されます。
  • 市場は用途別に神経変性疾患、がん、心血管疾患、脳卒中の4つに分類されます。心血管疾患分野は予測期間中も優位性を維持すると予想されます。DNA修復薬は、パーキンソン病やアルツハイマー病のような数多くの種類の心血管疾患を治療する可能性を秘めています。さらに、DNA修復によって治療の選択肢が提供される可能性もあります。
  • 同市場は、流通チャネルによって小売薬局、病院薬局、その他の2つに分類されます。ホスピタリティ部門は急速な成長が見込まれます。このセグメントの成長は、がんの有病率の上昇に起因しています。また、これらの薬剤は特殊であり、副作用の可能性もあるため、モニタリングや慎重な取り扱い、投与が必要となります。

DNA修復薬市場 - 地理的洞察

地理的には、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

DNA修復薬市場 - 競合情勢

DNA修復薬市場は、主要企業の存在により、世界的に非常に集中しています。また、様々なメーカーがそれぞれの地域で大きなシェアを占めています。先進国市場だけでなく新興国市場でも、がん罹患率の増加により、技術的に先進的な製品に対する需要が高まっています。市場プレーヤーが採用する成長戦略が世界市場を牽引する可能性が高いです。これに伴い、戦略にはM&A、革新的製品の発売、研究開発活動、提携などが含まれます。例えば、2022年3月、フロリダ州立大学医学部の研究者は、身体のDNA修復プロセスがどのように機能するかについての理解を変える発見をし、がんや他の疾患の新しい化学療法治療につながる可能性があります。

目次

第1章 DNA修復薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 DNA修復薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 DNA修復薬業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 DNA修復薬市場：COVID-19の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 DNA修復薬市場情勢

  • DNA修復薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 DNA修復薬市場 - 薬剤タイプ別

  • 概要
    • 薬剤タイプ別セグメントシェア分析
    • アルキル化剤
    • PARP阻害剤
    • トポイソメラーゼ阻害剤
    • その他

第8章 DNA修復薬市場 - 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 神経変性疾患
    • 腫瘍学的
    • 心血管疾患
    • 脳卒中

第9章 DNA修復薬市場 - 流通チャネル別

  • 概要
    • 流通チャネル別のセグメントシェア分析
    • 小売薬局
    • 病院薬局
    • その他

第10章 DNA修復薬市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - DNA修復薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Johnson &Johnson
    • Merck Kgaa
    • GlaxoSmithKline plc
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Abbvie Inc.
    • Pfizer Inc.
    • Amgen Inc.
    • Astrazeneca plc
    • Bristol-Myers Squibb Co.
    • Sanofi SA
    • Bayer AG
    • Eli Lilly
    • Gilead Sciences Inc.
    • Merck &Co. Inc.
    • Novartis AG

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE DNA Repair Drugs Market: Drug Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global DNA Repair Drugs Market, by Drug Type2018-2030 (USD Million)
  • TABLE DNA Repair Drugs Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global DNA Repair Drugs Market, by Application2018-2030 (USD Million)
  • TABLE DNA Repair Drugs Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global DNA Repair Drugs Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE DNA Repair Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global DNA Repair Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE EuropeDNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE DNA Repair Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Type segment market share analysis, 2022&2030
  • FIGURE Drug Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022&2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Europe DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Latin America DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa DNA Repair Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE Germany DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE India DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE Brazil DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1605

REPORT HIGHLIGHT

DNA repair drugs market size was valued at USD 6,005.2 Million in 2022, expanding at a CAGR of 12.8% from 2023 to 2030.

DNA repair drugs are defined as a class of pharmaceuticals that purpose to restore DNA functionality and integrity by helping to repair damaged DNA molecules. Moreover, these drugs are targeting particular DNA repair pathways and assist to restore DNA integrity as well as preventing the progression and development of several diseases, including cancer. The DNA repair drugs market is likely to witness significant growth due to increasing advancements and research activities in the field of molecular and genomics biology.

DNA Repair Drugs Market- Market Dynamics:

  • Increasing cases of cancer and growing healthcare infrastructure to fuel the market demand.
  • The increasing cases of cancer across the world have significantly raised the requirement for developing DNA damage response drugs for solving cancer unmet needs. These medications have hitherto unheard-of potential in providing a specific and effectively tolerated therapy method for boosting cancer survival rates. Moreover, DNA repair drugs are frequently associated with the idea of personalized medicine, where medical care is individualized based on a patient's genetic makeup as well as particular mutations. Thus, the drugs can be designed for selective genetic profiles; as a result, this trend helps to boost the potential market for these drugs. However, for market players, procuring regulatory approvals for DNA repair drugs could be a time-consuming and complex process that may restrain the market growth globally. Furthermore, the increasing healthcare expenditure and growing healthcare infrastructure in the emerging nation offer significant growth opportunities for DNA repair drug manufacturers. Additionally, these regions have an unmet need for effective treatments and a huge patient population creating a favorable market environment, which is projected to boost the DNA repair market growth.

DNA Repair Drugs Market- Key Insights:

  • As per the analysis shared by our research analyst, the global DNA repair drugs market is estimated to grow annually at a CAGR of around 12.8% over the forecast period (2023-2030)
  • The DNA repair drugs industry is projected to grow at a significant rate due to the rising incidence and prevalence of several cancers among the population increase the demand
  • Based on drug type segmentation, PARP inhibitors was predicted to show maximum market share in the near future
  • Based on application segmentation, cardiovascular diseases was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator during the forecast period

DNA Repair Drugs Market- Segmentation Analysis:

  • The global DNA repair drugs market is segmented on the basis of drug type, application, distribution channel, and region.
  • The market is divided into three categories based on drug type: alkylating agents, PARP inhibitors, topoisomerase inhibitors, and others. The PARP inhibitors segment is likely to possess the market share. The use of PARP inhibitors to target homologous recombination repair (HRR) pathways, tumors extensively in metastatic prostate cancer, and triple-negative breast cancer is expected to augment the market size over. Additionally, the utilization of PARP inhibitors including olaparib, niraparib, and rucaparib, in cancer patients with BRCA1/2 mutation and deficiency in HRR is projected to strengthen the segment value.
  • The market is divided into four categories based on application: neurodegenerative diseases, oncological, cardiovascular diseases, and stroke. The cardiovascular diseases segment is expected to maintain its dominance over the forecast period. DNA repair drugs have the potential in treating numerous types of cardiovascular diseases like Parkinson's and Alzheimer's. Moreover, therapeutic options could be provided by DNA repair.
  • The market is divided into two categories based on distribution channels: retail pharmacies, hospital pharmacies, and others. The hospital pharmacies segment is accounted to witness speedy growth. The segment growth is attributed due to the rising prevalence of cancer. Moreover, the specific nature of these drugs and their potential side effects, are likely to require monitoring, careful handling, and administration, as a result, such factors may propel the hospital pharmacies segment growth.

DNA Repair Drugs Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

DNA Repair Drugs Market- Competitive Landscape:

The DNA repair drugs market is highly concentrated across the globe owing to the presence of key players. Additionally, various manufacturers hold a major share in their respective regions. Demand for technologically advanced products has increased in developed as well as emerging markets, due to the increase in the prevalence of cancer. Growth strategies adopted by market players are likely to drive the global market. In line with this, the strategies include mergers & acquisitions, innovative product launches, R&D activities, and partnerships. For instance, in March 2022, a Florida State University College of Medicine researcher made a discovery that alters our understanding of how the body's DNA repair process works and may lead to new chemotherapy treatments for cancer and other diseases.

Recent Developments:

Furthermore, in February 2023, Artios Pharma Limited (Artios) introduced the initiation of a randomized, Phase 2 expansion cohort in the ongoing Phase 1/2 trial evaluating its ataxia telangiectasia and Rad3-related ("ATR") Inhibitor, ART0380, for the treatment of platinum-resistant ovarian cancer in combination with gemcitabine.

Key features of the study:

  • This proposed research study on DNA repair drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the DNA repair drugs market..
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for DNA repair drugs market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the DNA repair drugs market.
  • Impact of COVID-19 on DNA repair drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on DNA repair drugs market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the DNA repair drugs market, we have also included competitive landscape and key innovator analysis for the DNA repair drugs market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the DNA repair drugs market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global DNA repair drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DNA REPAIR DRUGS MARKET KEY PLAYERS

  • Johnson & Johnson
  • Merck Kgaa
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Abbvie Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Astrazeneca plc
  • Bristol-Myers Squibb Co.
  • Sanofi S.A.
  • Bayer AG
  • Eli Lilly
  • Gilead Sciences Inc.
  • Merck & Co. Inc.
  • Novartis AG

GLOBAL DNA REPAIR DRUGS MARKET, BY DRUG TYPE

  • Alkylating Agents
  • PARP Inhibitors
  • Topoisomerase Inhibitors
  • Other

GLOBAL DNA REPAIR DRUGS MARKET, BY APPLICATION

  • Neurodegenerative Diseases
  • Oncological
  • Cardiovascular Diseases
  • Stroke

GLOBAL DNA REPAIR DRUGS MARKET, BY DISTRIBUTION CHANNEL

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

GLOBAL DNA REPAIR DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. DNA Repair Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. DNA Repair Drugs Market Snippet by Drug Type
    • 2.1.2. DNA Repair Drugs Market Snippet by Application
    • 2.1.3. DNA Repair Drugs Market Snippet by Distribution Channel
    • 2.1.4. DNA Repair Drugs Market Snippet by Country
    • 2.1.5. DNA Repair Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. DNA Repair Drugs Key Market Trends

  • 3.1. DNA Repair Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. DNA Repair Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. DNA Repair Drugs Market Opportunities
  • 3.4. DNA Repair Drugs Market Future Trends

4. DNA Repair Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. DNA Repair Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. DNA Repair Drugs Market Landscape

  • 6.1. DNA Repair Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. DNA Repair Drugs Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022&2030 (%)
    • 7.1.2. Alkylating Agents
    • 7.1.3. PARP Inhibitors
    • 7.1.4. Topoisomerase Inhibitors
    • 7.1.5. Other

8. DNA Repair Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Neurodegenerative Diseases
    • 8.1.3. Oncological
    • 8.1.4. Cardiovascular Diseases
    • 8.1.5. Stroke

9. DNA Repair Drugs Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
    • 9.1.2. Retail Pharmacies
    • 9.1.3. Hospital Pharmacies
    • 9.1.4. Others

10. DNA Repair Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. DNA Repair Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. DNA Repair Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. DNA Repair Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. DNA Repair Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. DNA Repair Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- DNA Repair Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson
    • 11.2.2. Merck Kgaa
    • 11.2.3. GlaxoSmithKline plc
    • 11.2.4. Abbott Laboratories
    • 11.2.5. F. Hoffmann-La Roche Ltd.
    • 11.2.6. Abbvie Inc.
    • 11.2.7. Pfizer Inc.
    • 11.2.8. Amgen Inc.
    • 11.2.9. Astrazeneca plc
    • 11.2.10. Bristol-Myers Squibb Co.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. Bayer AG
    • 11.2.13. Eli Lilly
    • 11.2.14. Gilead Sciences Inc.
    • 11.2.15. Merck & Co. Inc.
    • 11.2.16. Novartis AG

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us